Flame retardant mattress sock passes flammability trial.
Flame retardancy and thermal management specialist Alexium International Group Limited’s (ASX: AJX) prototype foam mattress treatment systems have passed flammability testing required by US federal safety standards.
Underwriter Laboratories (UL), an independent third party, conducted the testing using FR socks treated with Alexiflam NF.
Alexium’s Chief Commercial Officer, Allen Reihman, said the testing met United States Consumer Product Safety Commission regulatory requirements with UL confirming that the barrier treated with Alexiflam NF passing the rigorous flammability test protocol.
Flame-retardant treatments reduce the chances of a fire starting and delay the spread of fire once it starts.
Current FR sock solutions use fiberglass technology to pass fire standards,” Mr Reihman said.
“Consumers are concerned with the health effects of shards of tiny glass that can migrate through the home.
“Mattress suppliers and brands are seeking solutions to this problem, and socks treated with Alexiflam NF contain no fiberglass.”
Mr Reihman said that by treating natural cotton instead of synthetic materials, Alexiflam NF provides a solution that is both sustainable and safe. Moreover, Alexiflam NF solutions are more affordable than fiberglass alternatives.
“Passing this critical safety test is a major milestone in our commercialisation of Alexiflam NF and validates our unwavering focus on innovation,” said Dr Robert Brookins, Alexium’s Chief Executive Officer.
“We’re progressing according to our growth plan by demonstrating our ability to successfully bring new product solutions to market quickly that align with customer needs. At this stage Alexium will begin working with new and existing customers on how they can use the FR cotton socks in their product lines.”
